Cooling Anesthesia for Intravitreal Injection With a Novel Device: Results of the Prospective COOL-2 Study

Related

• 

  Bacterial Dispersion Associated With Various Patient Face Mask Designs During Simulated Intravitreal Injections

  Samir N Patel, MD

  Annual Meeting Talks

  2021

• 

  2 Real-World Analyses of Treatment Burden Associated With Intravitreal Injections for DME Prior to 0.2 mcg/Day Fluocinolone Acetonide (FAc)

  Nancy M. Holekamp, MD, FASRS

  Annual Meeting Talks

  2018

• 

  Expert Panel: Faricimab and Aflibercept 8 mg in Diabetic Retinopathy

  Judy E. Kim, MD, FASRS

  Chirag D. Jhaveri, MD, FASRS

  Michael S. Ip, MD

  Arshad M. Khanani, MD, MA, FASRS

  Jordana G Fein, MD, MS

  Dennis M. Marcus, MD

  Diana V Do, MD, FASRS

  Annual Meeting Talks

  2024